Cancer Research SABCS  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 10, 644-646, October 1, 1950]
© 1950 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, L. L.
Right arrow Articles by Sugiura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, L. L., Jr.
Right arrow Articles by Sugiura, K.

Studies on the Distribution of Radioactive 8-Azaguanine (Guanazolo) in Mice with Eo771 Tumors* ,{dagger}

Leonard L. Bennett, Jr., Ph.D., Howard E. Skipper, Ph.D., Jack H. Mitchell, Jr., Ph.D. and Kanematsu Sugiura, Sc.D.

(From the Organic and Biochemistry Division, Southern Research Institute, Birmingham, Alabama, and the Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.)

Studies with 2-labeled 8-azaguanine (guanazolo) in normal and mammary adenocarcinoma-bearing mice have shown that very little of the 2-carbon atom is oxidized to carbon dioxide and exhaled, but that most of this atom is excreted in the urine. No evidence was obtained that the compound in question (or the 2-carbon therefrom) was preferentially accumulated, fixed, or incorporated in Eo771 tumors, which are known to be inhibited by 8-azaguanine.

* This investigation was supported by grants from the American Cancer Society, on recommendation of the Committee on Growth; Mr. Ben May, Mobile, Alabama; and the Institute Sponsored Research Fund of Southern Research Institute. The development of a tracer scale synthesis for 8-azaguanine-2-C14 was carried out under a grant from the Isotopes Division, Atomic Energy Commission.

{dagger} The authors wish to acknowledge the technical assistance of Miss Margaret Ann Newton, Miss Linda Simpson, Miss Martelia Bell, and Mrs. Juanita B. Chapman.

Received 6/21/50.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1950 by the American Association for Cancer Research.